JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients

por Shahriari, Neda, Strober, Bruce, Shahriari, Mona
Publicado 2023

Combined biologic therapy for the treatment of psoriasis and psoriatic arthritis: A case report

por Babalola, Olubukola, Lakdawala, Nikita, Strober, Bruce E.
Publicado 2014

Interferon beta-1a–induced morphea

por Bezalel, Spencer A., Strober, Bruce E., Ferenczi, Katalin
Publicado 2014

Substantial Alterations of the Cutaneous Bacterial Biota in Psoriatic Lesions

por Gao, Zhan, Tseng, Chi-hong, Strober, Bruce E., Pei, Zhiheng, Blaser, Martin J.
Publicado 2008

A Survey of Community Dermatologists Reveals the Unnecessary Impact of Trial-and-Error Behavior on the Psoriasis Biologic Treatment Paradigm

por Strober, Bruce, Pariser, David, Deren-Lewis, Ann, Dickerson, Tobin J., Lebwohl, Mark, Menter, Alan
Publicado 2021

Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting

por Strober, Bruce, Patil, Dhaval, McLean, Robert R., Moore-Clingenpeel, Melissa, Guo, Ning, Levi, Eugenia, Lebwohl, Mark
Publicado 2022

Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

por Ghosh, Subrata, Gensler, Lianne S., Yang, Zijiang, Gasink, Chris, Chakravarty, Soumya D., Farahi, Kamyar, Ramachandran, Paraneedharan, Ott, Elyssa, Strober, Bruce E.
Publicado 2019

Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

por Ghosh, Subrata, Gensler, Lianne S., Yang, Zijiang, Gasink, Chris, Chakravarty, Soumya D., Farahi, Kamyar, Ramachandran, Paraneedharan, Ott, Elyssa, Strober, Bruce E.
Publicado 2019

Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psorias...

por Strober, Bruce, Greenberg, Jeffrey D, Karki, Chitra, Mason, Marc, Guo, Ning, Hur, Peter, Zhao, Yang, Herrera, Vivian, Lin, Feng, Lebwohl, Mark
Publicado 2019

The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases

por Ramcharran, Darmendra, Strober, Bruce, Gordon, Kenneth, DeKlotz, Cynthia, Fakharzadeh, Steven, Yang, Ya-Wen, Swerdel, Joel, Hardin, Jill, Dronavalli, Sridhar, Paller, Amy S.
Publicado 2023

Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists

por Strober, Bruce, Kotowsky, Nirali, Medeiros, Rose, Mackey, Rachel H., Harrold, Leslie R., Valdecantos, Wendell C., Flack, Mary, Golembesky, Amanda K., Lebwohl, Mark
Publicado 2021

Efficacy and safety of mirikizumab in psoriasis: results from a 52‐week, double‐blind, placebo‐controlled, randomized withdrawal, phase III trial (OASIS‐1)

por Blauvelt, Andrew, Kimball, Alexa B., Augustin, Matthias, Okubo, Yukari, Witte, Michael M., Capriles, Claudia Rodriguez, Sontag, Angelina, Arora, Vipin, Osuntokun, Olawale, Strober, Bruce
Publicado 2022

Community differentiation of the cutaneous microbiota in psoriasis

por Alekseyenko, Alexander V, Perez-Perez, Guillermo I, De Souza, Aieska, Strober, Bruce, Gao, Zhan, Bihan, Monika, Li, Kelvin, Methé, Barbara A, Blaser, Martin J
Publicado 2013

The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score

por Papp, Kim A., Lebwohl, Mark G., Kircik, Leon H., Pariser, David M., Strober, Bruce, Krueger, Gerald G., Berk, David R., Navale, Lynn, Higham, Robert C.
Publicado 2021

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis rece...

por Kristensen, Lars E., Strober, Bruce, Poddubnyy, Denis, Leung, Ying-Ying, Jo, Hyejin, Kwok, Kenneth, Vranic, Ivana, Fleishaker, Dona L., Fallon, Lara, Yndestad, Arne, Gladman, Dafna D.
Publicado 2023

Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study

por Kimball, Alexa B., Delevry, Dimittri, Yang, Min, Chuang, Chien-Chia, Wang, Zhixiao, Bégo-Le-Bagousse, Gaëlle, Martins, Bruno, Wu, Eric, Shumel, Brad, Wang, Jessie, Sierka, Debra, Chao, Jingdong, Strober, Bruce
Publicado 2023

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17

por Armstrong, April W., Blauvelt, Andrew, Mrowietz, Ulrich, Strober, Bruce, Gisondi, Paolo, Merola, Joseph F., Langley, Richard G., Ståhle, Mona, Lebwohl, Mark, Netea, Mihai G., Nunez Gomez, Natalie, Warren, Richard B.
Publicado 2022

Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry

por Gottlieb, Alice B., Merola, Joseph F., Cirulli, Joshua, Williams, Catherine C., Linowski, Gregory J., Paris, Maria, Litman, Heather J., Guo, Ning, Emeanuru, Kelechi, McLean, Robert R., Cronin, Angel, Strober, Bruce
Publicado 2021

Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry

por Lockshin, Benjamin, Cronin, Angel, Harrison, Ryan W., McLean, Robert R., Anatale‐Tardiff, Laura, Burge, Russel, Zhu, Baojin, Malatestinic, William N., Atiya, Bilal, Murage, Mwangi J., Gallo, Gaia, Strober, Bruce, Van Voorhees, Abby
Publicado 2021

Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line

por Strober, Bruce, Leman, Joyce, Mockenhaupt, Maja, Nakano de Melo, Juliana, Nassar, Ahmed, Prajapati, Vimal H., Romanelli, Paolo, Seneschal, Julien, Tsianakas, Athanasios, Wei, Lee Yoong, Yasuda, Masahito, Yu, Ning, Hernandez Daly, Ana C., Okubo, Yukari
Publicado 2021